| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/28/2007 | US20070149768 Specific human antibodies for selective cancer therapy |
| 06/28/2007 | US20070149761 To evaluate the effectiveness of a compound to inhibit NS5B activity |
| 06/28/2007 | US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070149450 Method for reducing levels of c-reactive protein |
| 06/28/2007 | US20070149446 Tamandarin analogs and fragments thereof and methods of making and using |
| 06/28/2007 | US20070149439 Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo |
| 06/28/2007 | US20070148774 Methods for producing members of specific binding pairs |
| 06/28/2007 | US20070148735 Novel chromophores/fluorophores and methods for using the same |
| 06/28/2007 | US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 06/28/2007 | US20070148718 Fas binding antibodies |
| 06/28/2007 | US20070148714 Clinical Parameters for Determining Hematologic Toxicity Prior to Radioimmunotherapy |
| 06/28/2007 | US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070148706 Pancreatic progenitor cells and methods for isolating the same |
| 06/28/2007 | US20070148700 Site-specific aminoglycoside derivatives for use in immunodiagnostic assays |
| 06/28/2007 | US20070148692 KCNQ potassium channels and methods of modulating same |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148686 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 06/28/2007 | US20070148685 Capture, Concentration And Quantitation Of Abnormal Prion Protein From Biological Fluids Using Depth Filtration |
| 06/28/2007 | US20070148191 Use of ligands of specific antigen for the diagnosis and treatment of solid tumours and bone-related cancerous diseases |
| 06/28/2007 | US20070148180 Peptide-immunoglobulin-conjugate |
| 06/28/2007 | US20070148179 Gankyrin |
| 06/28/2007 | US20070148178 Using beacizumab and antitumor agent as therapeutic treatment for mesothelioma |
| 06/28/2007 | US20070148177 Treatment with anti-vegf antibodies |
| 06/28/2007 | US20070148174 Admixing with monoclonal antibodies; binds to ribonuclease; DNA or RNA maintains its intact, full-length form during production and storage |
| 06/28/2007 | US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6 |
| 06/28/2007 | US20070148172 Method for the treatment of inflammatory bowel disease |
| 06/28/2007 | US20070148171 Optimized anti-CD30 antibodies |
| 06/28/2007 | US20070148170 Fc Variants With Optimized Fc Receptor Binding Properties |
| 06/28/2007 | US20070148169 Therapeutic agent for chronic arthritides diseases of childhood-related diseases |
| 06/28/2007 | US20070148167 Non-immunostimulatory antibody and compositions containing the same |
| 06/28/2007 | US20070148166 Scfvs in photosynthetic microbes |
| 06/28/2007 | US20070148165 Recombinant antibody composition |
| 06/28/2007 | US20070148164 Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
| 06/28/2007 | US20070148163 Mutants of anti-cd40 antibody |
| 06/28/2007 | US20070148162 Molecule which binds cd80 and cd86 |
| 06/28/2007 | US20070148143 Human cytokine receptor |
| 06/28/2007 | US20070148126 comprising a fibronectin type III tenth (10Fn3) domain of 80 to 150 amino acids; Angiogenesis |
| 06/28/2007 | US20070148095 Fluorescent magnetic nanoparticles with specific targeting functions |
| 06/28/2007 | US20070148089 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2007 | DE102005060813A1 Selektive Markierung der Glykane von Antikörpern mit modifizierten Nukleotidzuckern als Substrate von rekombinanten Galactosyltransferasen Selective labeling of glycans of antibodies with modified nucleotide sugars as substrates of recombinant galactosyltransferases |
| 06/28/2007 | CA2634116A1 Anti-ilt7 antibody |
| 06/28/2007 | CA2634083A1 Chimeric antibodies with part new world primate binding regions |
| 06/28/2007 | CA2634080A1 Anti-inflammatory dab |
| 06/28/2007 | CA2633793A1 Methods of clustering gene and protein sequences |
| 06/28/2007 | CA2633766A1 Pharmaceutical compositions comprising a bispecific single chain antibody with specificity for human cd3 and human cea and having resistance to soluble cea |
| 06/28/2007 | CA2633756A1 Pharmaceutical antibody compositions with resistance to soluble cea |
| 06/28/2007 | CA2633713A1 Epha2 bite molecules and uses thereof |
| 06/28/2007 | CA2633699A1 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/28/2007 | CA2633331A1 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | CA2633213A1 Soluble gp130 molecule variants useful as a medicament |
| 06/28/2007 | CA2633138A1 Methods for generating and screening fusion protein libraries and uses thereof |
| 06/27/2007 | EP1801594A1 Sensing device and method for determination of the amount of target molecule in an analyte |
| 06/27/2007 | EP1801592A1 Hepatitis C virus NS2/3 assay |
| 06/27/2007 | EP1801591A2 Methods for detection or measurement of viruses |
| 06/27/2007 | EP1801219A2 Neisserial antigenic peptides |
| 06/27/2007 | EP1801218A2 Nucleic acids and proteins from streptococcus pneumoniae |
| 06/27/2007 | EP1801208A1 Anti-a33 antibody |
| 06/27/2007 | EP1801124A1 Utilization of sperm membrane protein obf |
| 06/27/2007 | EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 06/27/2007 | EP1801121A1 Soluble gp130 molecule variants useful as a medicament |
| 06/27/2007 | EP1801119A1 Interleukin-15 antagonist peptide |
| 06/27/2007 | EP1800693A1 Adjuvant therapy with the use of anti-glypican 3 antibody |
| 06/27/2007 | EP1800673A2 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/27/2007 | EP1800128A2 Methods for determining and lowering caffeine concentration in fluids |
| 06/27/2007 | EP1800124A2 Image based quantitation of molecular translocation |
| 06/27/2007 | EP1799813A2 System and method for production of antibodies in plant cell culture |
| 06/27/2007 | EP1799718A1 Vaccine |
| 06/27/2007 | EP1799717A2 Isolating human antibodies |
| 06/27/2007 | EP1799712A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 06/27/2007 | EP1799705A1 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 06/27/2007 | EP1799700A2 Srage mimetibody, compositions, methods and uses |
| 06/27/2007 | EP1799259A1 Binding molecules for treatment and detection of cancer |
| 06/27/2007 | EP1799256A2 Method of eliciting an immune response against hiv |
| 06/27/2007 | EP1799252A1 Antibody production method |
| 06/27/2007 | EP1799243A2 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway |
| 06/27/2007 | EP1220923B1 FACTOR IX/FACTOR IXa ACTIVATING ANTIBODIES |
| 06/27/2007 | EP1218519B1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 06/27/2007 | EP1121436B1 Non-desensitizing ampa-receptors |
| 06/27/2007 | EP1110086B1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 06/27/2007 | EP1107986B1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/27/2007 | EP0981549B2 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 06/27/2007 | EP0980387B1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 06/27/2007 | EP0964250B1 Diagnostic drugs for autoimmune diseases |
| 06/27/2007 | EP0934530B1 Immunological composition for detection of bladder cancer and method of using same |
| 06/27/2007 | EP0851870B1 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 06/27/2007 | CN1989154A Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| 06/27/2007 | CN1988917A Phep, an amino acid permease of staphylococcus aureus |
| 06/27/2007 | CN1986811A Japanese blood fluke epiderm gene and its coded protein and application |
| 06/27/2007 | CN1986810A Japanese blood fluke epiderm antigen and candidate vaccine gene and pretin and their application |
| 06/27/2007 | CN1986809A Japanese blood fluke epiderm antigen gene and protein and their application |
| 06/27/2007 | CN1986808A Japanese blood fluke specific epiderm gene and protein and their application |
| 06/27/2007 | CN1986807A Japanese blood fluke epidermal antigen gene and protein and their application |
| 06/27/2007 | CN1986806A Japanese blood fluke epidermal antigen gene and protein and their application |
| 06/27/2007 | CN1986805A Specific protein gene and protein of female blood fluke and their application |
| 06/27/2007 | CN1986804A Japanese blood fluke specific epiderm gene and its coded protein and application |
| 06/27/2007 | CN1986803A Japanese blood fluke epiderm gene and its coded protein and application |
| 06/27/2007 | CN1986802A Japanese blood fluke epidermal antigen gene and its coded protein and application |
| 06/27/2007 | CN1986801A Japanese blood fluke specific epiderm antigen gene and protein and their application |
| 06/27/2007 | CN1986800A Japanese blood fluke specific epiderm antigen gene and its coded protein and application |
| 06/27/2007 | CN1986799A Japanese blood fluke epidermal gene and its coded protein and application |